Hacking Pancreatic Cancer: Present and Future of Personalized Medicine

Pancreatic cancer (PC) is a recalcitrant disease characterized by high incidence and poor prognosis. The extremely complex genomic landscape of PC has a deep influence on cultivating a tumor microenvironment, resulting in the promotion of tumor growth, drug resistance, and immune escape mechanisms....

詳細記述

書誌詳細

出版年:	Pharmaceuticals
主要な著者:	Alessandro Di Federico, Valentina Tateo, Claudia Parisi, Francesca Formica, Riccardo Carloni, Giorgio Frega, Alessandro Rizzo, Dalia Ricci, Mariacristina Di Marco, Andrea Palloni, Giovanni Brandi
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2021-07-01
主題:	pancreatic cancer immunotherapy targeted therapy tyrosine kinase inhibitor personalized medicine metabolism
オンライン･アクセス:	https://www.mdpi.com/1424-8247/14/7/677